Effects of GH secretagogues on contractility and Ca2+ homeostasis of isolated adult rat ventricular myocytes

Endocrinology

Volumn 151, Issue 9, 2010, Pages 4446-4454

  Sun, Qiang ^a,b   Ma, Yi ^b   Zhang, Lin ^b   Zhao, Yu Feng ^b   Zang, Wei Jin ^a   Chen, Chen ^a,b  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM CHANNEL; CARBAZOLE DERIVATIVE; CYCLIC AMP DEPENDENT PROTEIN KINASE; ENZYME INHIBITOR; GHRELIN; GHRELIN RECEPTOR; GHRP-6, LYS(3)-; HEXARELIN; KT 5720; OLIGOPEPTIDE; PYRROLE DERIVATIVE;

ANIMAL; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CELL SHAPE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECTS; HEART MUSCLE CELL; HEART VENTRICLE; HOMEOSTASIS; MALE; MEMBRANE POTENTIAL; METABOLISM; PHYSIOLOGY; RAT; SARCOMERE; WISTAR RAT;

ANIMALS; CALCIUM; CALCIUM CHANNELS; CARBAZOLES; CELL SHAPE; CELLS, CULTURED; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GHRELIN; HEART VENTRICLES; HOMEOSTASIS; MALE; MEMBRANE POTENTIALS; MYOCYTES, CARDIAC; OLIGOPEPTIDES; PYRROLES; RATS; RATS, WISTAR; RECEPTORS, GHRELIN; SARCOMERES;

EID: 77956031818     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-1432     Document Type: Article

References (35)

1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K 1999 Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656-660 (Pubitemid 129516334)
2. Pang JJ, Xu RK, Xu XB, Cao JM, Ni C, Zhu WL, Asotra K, Chen MC, Chen C 2004 Hexarelin protects rat cardiomyocytes from angiotensin II-induced apoptosis in vitro. Am J Physiol Heart Circ Physiol 286:H1063-H1069
3. Cao JM, Ong H, Chen C 2006 Effects of ghrelin and synthetic GH secretagogues on the cardiovascular system. Trends Endocrinol Metab 17:13-18
4. Gnanapavan S, Kola B, Bustin SA, Morris DG, McGee P, Fairclough P, Bhattacharya S, Carpenter R, Grossman AB, Korbonits M 2002 The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 87:2988
5. Nagaya N, Kojima M, Uematsu M, Yamagishi M, Hosoda H, Oya H, Hayashi Y, Kangawa K 2001 Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am J Physiol Regul Integr Comp Physiol 280:R1483-R1487
6. Bisi G, Podio V, Valetto MR, Broglio F, Bertuccio G, Aimaretti G, Pelosi E, Del Rio G, Muccioli G, Ong H, Boghen MF, Deghenghi R, Ghigo E 1999 Cardiac effects of hexarelin in hypopituitary adults. Eur J Pharmacol 381:31-38
7. Bisi G, Podio V, Valetto MR, Broglio F, Bertuccio G, Del Rio G, Arvat E, Boghen MF, Deghenghi R, Muccioli G, Ong H, Ghigo E 1999 Acute cardiovascular and hormonal effects of GH and hexarelin, a synthetic GH-releasing peptide, in humans. J Endocrinol Invest 22:266-272
8. Xu XB, Cao JM, Pang JJ, Xu RK, Ni C, Zhu WL, Asotra K, Chen MC, Chen C 2003 The positive inotropic and calcium-mobilizing effects of growth hormone-releasing peptides on rat heart. Endocrinology 144:5050-5057
9. Bodart V, Febbraio M, Demers A, McNicoll N, Pohankova P, Perreault A, Sejlitz T, Escher E, Silverstein RL, Lamontagne D, Ong H 2002 CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart. Circ Res 90:844-849
10. Iwase M, Kanazawa H, Kato Y, Nishizawa T, Somura F, Ishiki R, Nagata K, Hashimoto K, Takagi K, Izawa H, Yokota M 2004 Growth hormone-releasing peptide can improve left ventricular dysfunction and attenuate dilation in dilated cardiomyopathic hamsters. Cardiovasc Res 61:30-38
11. Nagaya N, Moriya J, Yasumura Y, Uematsu M, Ono F, Shimizu W, Ueno K, Kitakaze M, Miyatake K, Kangawa K 2004 Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation 110:3674-3679
12. Soeki T, Kishimoto I, Schwenke DO, Tokudome T, Horio T, Yoshida M, Hosoda H, Kangawa K 2008 Ghrelin suppresses cardiac sympathetic activity and prevents early left ventricular remodeling in rats with myocardial infarction. Am J Physiol Heart Circ Physiol 294:H426-H432
13. Xu XB, Pang JJ, Cao JM, Ni C, Xu RK, Peng XZ, Yu XX, Guo S, Chen MC, Chen C 2005 GH-releasing peptides improve cardiac dysfunction and cachexia and suppress stress-related hormones and cardiomyocyte apoptosis in rats with heart failure. Am J Physiol Heart Circ Physiol 289:H1643-H1651
14. Rossoni G, Locatelli V, Gennaro Colonna Vd, Müller EE, Berti F 2000 Hexarelin, a growth hormone secretagogue, protects the isolated rat heart from ventricular dysfunction produced by exposure to calcium-free medium. Pharmacol Res 42:129-136 (Pubitemid 30658941)
15. Locatelli V, Rossoni G, Schweiger F, Torsello A, De Gennaro Colonna V, Bernareggi M, Deghenghi R, Müller EE, Berti F 1999 Growth hormone-independent cardioprotective effects of hexarelin in the rat. Endocrinology 140:4024-4031
16. Xu X, Pang J, Yin H, Li M, Hao W, Chen C, Cao JM 2007 Hexarelin suppresses cardiac fibroblast proliferation and collagen synthesis in rat. Am J Physiol Heart Circ Physiol 293:H2952-H2958
17. Marleau S, Mulumba M, Lamontagne D, Ong H 2006 Cardiac and peripheral actions of growth hormone and its releasing peptides: relevance for the treatment of cardiomyopathies. Cardiovasc Res 69:26-35
18. Bedendi I, Gallo MP, Malan D, Levi RC, Alloatti G 2001 Role of endothelial cells in modulation of contractility induced by hexarelin in rat ventricle. Life Sci 69:2189-2201
19. Soares JB, Rocha-Sousa A, Castro-Chaves P, Henriques-Coelho T, Leite-Moreira AF 2006 Inotropic and lusitropic effects of ghrelin and their modulation by the endocardial endothelium, NO, prostaglandins, GHS-R1a and KCa channels. Peptides 27:1616-1623
20. Soares JB, Rocha-Sousa A, Castro-Chaves P, Henriques-Coelho T, Lourenço AP, Roncon-Albuquerque Jr R, Leite-Moreira AF 2005 Contractile effects of ghrelin and expression of its receptor GHS-R1a in normal and hypertrophic myocardium. Rev Port Cardiol 24:1235-1242
21. Bedendi I, Alloatti G, Marcantoni A, Malan D, Catapano F, Ghé C, Deghenghi R, Ghigo E, Muccioli G 2003 Cardiac effects of ghrelin and its endogenous derivatives des-octanoyl ghrelin and des-Gln14-ghrelin. Eur J Pharmacol 476:87-95
22. Zang WJ, Yu XJ, Honjo H, Kirby MS, Boyett MR 1993 On the role of G protein activation and phosphorylation in desensitization to acetylcholine in guinea-pig atrial cells. J Physiol 464:649-679
23. Sun Q, Zang WJ, Chen C 2010 Growth hormone secretagogues reduce transient outward K+ current via phospholipase C/protein kinase C signaling pathway in rat ventricular myocytes. Endocrinology 151:1228-1235
24. Bers DM 2002 Cardiac excitation-contraction coupling. Nature 415:198-205
25. Erriquez J, Bernascone S, Ciarletta M, Filigheddu N, Graziani A, Distasi C 2009 Calcium signals activated by ghrelin and D-Lys(3)-GHRP-6 ghrelin antagonist in developing dorsal root ganglion glial cells. Cell Calcium 46:197-208
26. Wu D, Chen C, Zhang J, Bowers CY, Clarke IJ 1996 The effects of GH-releasing peptide-6 (GHRP-6) and GHRP-2 on intracellular adenosine 3′,5′-monophosphate (cAMP) levels and GH secretion in ovine and rat somatotrophs. J Endocrinol 148:197-205 (Pubitemid 26046916)
27. Chang L, Ren Y, Liu X, Li WG, Yang J, Geng B, Weintraub NL, Tang C 2004 Protective effects of ghrelin on ischemia/reperfusion injury in the isolated rat heart. J Cardiovasc Pharmacol 43:165-170
28. King MK, Gay DM, Pan LC, McElmurray 3rd JH, Hendrick JW, Pirie C, Morrison A, Ding C, Mukherjee R, Spinale FG 2001 Treatment with a growth hormone secretagogue in a model of developing heart failure: effects on ventricular and myocyte function. Circulation 103:308-313
29. Tivesten A, Bollano E, Caidahl K, Kujacic V, Sun XY, Hedner T, Hjalmarson A, Bengtsson BA, Isgaard J 2000 The growth hormone secretagogue hexarelin improves cardiac function in rats after experimental myocardial infarction. Endocrinology 141:60-66
30. Kojima M, Hosoda H, Matsuo H, Kangawa K 2001 Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Trends Endocrinol Metab 12:118-122 (Pubitemid 33714199)
31. Hosoda H, Kojima M, Kangawa K 2006 Biological, physiological, and pharmacological aspects of ghrelin. J Pharmacol Sci 100:398-410 (Pubitemid 44609531)
32. Baldanzi G, Filigheddu N, Cutrupi S, Catapano F, Bonissoni S, Fubini A, Malan D, Baj G, Granata R, Broglio F, Papotti M, Surico N, Bussolino F, Isgaard J, Deghenghi R, Sinigaglia F, Prat M, Muccioli G, Ghigo E, Graziani A 2002 Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J Cell Biol 159:1029-1037
33. Chen C 2000 Growth hormone secretagogue actions on the pituitary gland: multiple receptors for multiple ligands? Clin Exp Pharmacol Physiol 27:323-329
34. Treinys R, Jurevicius J 2008 L-type Ca2+ channels in the heart: structure and regulation. Medicina 44:491-499
35. Yang L, Doshi D, Morrow J, Katchman A, Chen X, Marx SO 2009 Protein kinase C isoforms differentially phosphorylate Ca (v) 1.2α(1c). Biochemistry 48:6674-6683